CDC - New CDC Publications - TB Notes 3, 2010 - TB

TB Notes Newsletter
(PDF - 1.6M)
download, 40 pages:
http://www.cdc.gov/tb/publications/newsletters/notes/TBN_3_10/images/tbn310.pdf

No. 3, 2010
New CDC Publications
contents:
Anger HA, Dworkin F, Sharma S, Munsiff SS, Nilsen DM, Ahuja SD. Linezolid use for treatment of multidrug-resistant and extensively drug-resistant tuberculosis, New York City, 2000-06. J Antimicrobial Chemotherapy 2010 April; 65(4): 775-783.

Anuwatnonthakate A, Jittimanee SX, Cain J, Nateniyom S, Wattanaamornkiat W, Komsakorn S, Moolphate S, Banyati P, Chiengsorn N, Limsomboon P, Kaewsa-Ard S, Varma JK. Barriers to human immunodeficiency virus testing of tuberculosis patients in Thailand, 2004-2007. Int J Tuberc Lung Dis 2010 Aug;14(8):980-5.

Blaya JA, Shin SS, Yale G, Suarez C, Asencios L, Contreras C, Rodriguez P, Kim J, Cegielski P, Fraser HSF. Electronic laboratory system reduces errors in National Tuberculosis Program: a cluster randomized controlled trial. Int J Tuberc Lung Dis 2010 Aug; 14 (8): 1009-1015.

Buff AM, Moonan PK, Desai MA, McKenna TL, Harris DA, Rogers BJ, Rabley SS, Oeltmann JE. South Carolina tuberculosis genotype cluster investigation: a tale of substance abuse and recurrent disease. [Notes from the field.] Int J Tuberc Lung Dis 2010 Oct; 14(10): 1347-1349.

Chauhan LS, Wares F, Sahu S, Dewan P, Chadha S, Thirumala A, Ramachandran R. Drug resistance in Kerala. [Correspondence.] Int J Tuberc Lung Dis 2010 May; 14(5): 660-661.

Goldberg S, LoBue P. Pulmonary tuberculosis: focus on the fluoroquinolones. Clinical Medicine Insights: Therapeutics 2010;2: 341–352.
Kane S, Dewan PK, Gupta D, Wi T, Das A, Singh A, Bitra G, Chauhan LS, Dallabetta G. Large-scale public-private partnership for improving TB-HIV services for high-risk groups in India. [Notes from the Field.] Int J Tuberc Lung Dis 2010 Aug; 14(8):1066–1068.

Kornylo-Duong K, Kim C, Cramer EH, Buff AM, Rodriguez-Howell D, Doyle J, Higashi J, Fruthaler CS, Robertson CL, Marienau KJ. Three air travel-related contact investigations associated with infectious tuberculosis, 2007–2008. Travel Medicine and Infectious Disease 2010 March; 8(2): 120-128.

Leinhardt C, Vernon A, Raviglione Mario C. New drugs and new regimens for the treatment of tuberculosis: review of the drug development pipeline and implications for national programmes. Current Opinion in Pulmonary Medicine 2010 May; 16(3): 186-193.

LoBue PA, Enarson DA, Thoen CO. Tuberculosis in humans and animals: an overview. [Serialised article. Tuberculosis: a re-emerging disease in animals and humans. Number 1 in the series]. Int J Tuberc Lung Dis 2010 Sept; 14(9): 1075-1078.

LoBue PA, Enarson DA, Thoen TC. Tuberculosis in humans and its epidemiology, diagnosis and treatment in the United States. [Serialised article. Tuberculosis: a re-emerging disease in animals and humans. Number 2 in the series]. Int J Tuberc Lung Dis 2010 Oct; 14(10): 1226-1232.

LoBue P, Menzies D. Treatment of latent tuberculosis infection: an update. Respirology 2010 May; 15(4): 603-622.

Lönnroth K, Castro KG, Chakaya JM, Chauhan LS, Floyd K, Glaziou P, Raviglione MC. Tuberculosis control and elimination 2010-50: cure, care, and social development. Lancet 2010 May 18. [Epub ahead of print.]

Lönnroth K, Williams BG, Cegielski P, Dye C. A consistent log-linear relationship between tuberculosis incidence and body mass index. Int J Epidemiology 2010 Feb; 39(1): 149-155.

Menzies HJ, Winston CA, Holtz TH, Cain KP, Mac Kenzie WR. Epidemiology of tuberculosis among US- and foreign-born children and adolescents in the United States, 1994–2007. Am J Public Health July 15, 2010. [Epub ahead of print.]

Metcalfe JZ, Cattamanchi A, Vittinghoff E, Ho C, Grinsdale J, Hopewell PC, Kawamura LM, Nahid P. Evaluation of quantitative IFN-{gamma} response for risk stratification of active tuberculosis suspects. Am J Respir Crit Care Med 2010;181:87-93.

Nabbuye-Sekandi J, Okot-Chono R, Rusen ID, Dlodlo RA, Katamba A, Tumwesigye NM, Fujiwara PI. Factors associated with human immunodeficiency virus testing among tuberculosis patients receiving treatment at health facilities in Uganda. Int J Tuberc Lung Dis 2010 July; 14(7): 896-902.

Nahid P, Bliven EE, Kim EY, Mac Kenzie WR, Stout JE, Diem L, Johnson JL, Gagneux S, Hopewell PC, Kato-Maeda M; for the Tuberculosis Trials Consortium. Influence of M. tuberculosis lineage variability within a clinical trial for pulmonary tuberculosis. PLoS One 2010 May 20;5(5):e10753.

Pai M, Castro K, Mori T, Lienhardt C. Proceedings of the Second Global Symposium on Interferon-Gamma Release Assays. Session 9, Guidelines. Int J Tuberc Lung Dis 2010 June Suppl 1; 14: S64-S69.

Ramirez MV, Cowart KC, Campbell PJ, Morlock GP, Sikes D, Winchell JM, Posey JE. Rapid detection of multidrug resistant tuberculosis using real-time PCR and high resolution melt analysis. J Clin Microbiol 2010 Sep 1. [Epub ahead of print.]

Rodwell TC, Barnes RFW, Moore M, Strathdee SA, Raich A, Moser KS, Garfein RS. HIV-tuberculosis coinfection in southern California: evaluating disparities in disease burden. Am J Public Health 2010 April; 100 Suppl 1: S178-S185.

Schecter GF, Scott C, True L, Raftery A, Flood J, and Mase S. Linezolid in the treatment of multidrug‐resistant tuberculosis. Clin Infect Dis 2010 Jan; 50:49–55.

Tedla Z, Nyirenda S, Peeler C, Agizew T, Sibanda T, Motsamai O, Vernon A, Wells CD, and Samandari T. Isoniazid-associated hepatitis and antiretroviral drugs during tuberculosis prophylaxis in HIV-infected adults in Botswana. Am J Respir Crit Care Med 2010; 182: 278-285.

Thoen CO, LoBue PA, de Kantor I. Why has zoonotic tuberculosis not received much attention? [Editorial.] Int J Tuberc Lung Dis 2010 Sept; 14(9):1073–1074.

Vinnard C, Winston CA, Wileyto EP, MacGregor RR, Bisson GP. Isoniazid resistance and death in patients with tuberculous meningitis: retrospective cohort study. BMJ 2010 Sept 7. [Epub ahead of print.]

Weiner M, Peloquin C, Burman W, Luo CC, Engle M, Prihoda TJ, Mac Kenzie WR, Bliven-Sizemore E, Johnson JL, Vernon A. The effects of tuberculosis, race and human gene SLCO1B1 polymorphisms on rifampin concentrations. Antimicrob Agents Chemother 2010 Jul 26. [Epub ahead of print].

Winston C, Navin T. Birth cohort effect on latent tuberculosis infection prevalence, United States. BMC Infectious Diseases 2010; 10:206.

Wongsrichanalai C, Varma JK, Juliano JJ, Kimerling ME, MacArthur JR. Extensive drug resistance in malaria and tuberculosis. Emerg Infect Dis [online] 2010 Jul.


open here please or see above:
CDC - New CDC Publications - TB Notes 3, 2010 - TB